Comments
AstraZeneca Pharma has fixed the floor price at Rs 854.1 a piece for delisting its shares from stock exchanges.
Astrazeneca Pharmaceuticals AB, Sweden, holds 75 per cent stake in AstraZeneca Pharma India. Astrazeneca Pharmaceuticals AB, the promoter of the company has informed that the “floor price in relation to the delisting proposal has been fixed at Rs 854.1 per equity share,” the company said in a filing to the BSE.
AstraZeneca said that increase in promoter’s ownership in the company will provide with greater operational flexibility to support the business.
Last month, AstraZeneca Pharma had received by email a letter from the promoter proposing to make a voluntary delisting offer to the public shareholders from stock exchanges.
The company on March 18 had announced that its board approved delisting of the company’s shares from bourses.
Shares of the company today closed at Rs 1,092.80 a share on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.